Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment
HRS9531 achieves significant weight reduction in Phase 3 trial, with plans for NDA submission in China and global development as…
Emcure Pharmaceuticals and Sanofi India sign exclusive distribution agreement for oral anti-diabetic…
Partnership aims to improve access to Amaryl and Cetapin through Emcure’s distribution network, addressing rising diabetes burden…
Panel Discussion: Future-ready formulations: Addressing the challenges of special populations
FDD Conclave 2025 | 14th June 2025 | Hyderabad
Panel Discussion: Beyond the needle: Innovations in painless drug delivery
FDD Conclave 2025 | 14th June 2025 | Hyderabad
Panel Discussion: Topical and transdermal drug delivery: The rise of non-invasive therapies
FDD Conclave 2025 | 14th June 2025 | Hyderabad
Dr Pavan Bhat, CEO, Inventia Healthcare
FDD Conclave 2025 | 14th June 2025 | Hyderabad
Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development
FDD Conclave 2025 | 13th June 2025 | Hyderabad
Mr Akil Kadiyavala, GM – Technical Services, Dhara Lifescience
FDD Conclave 2025 | 13th June 2025 | Hyderabad
Dr Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities
FDD Conclave 2025 | 13th June 2025 | Hyderabad